CK-302

N/A

Report date: 2024/05/09 16:47:19

Base Information

Drug NameCK-302
Drug Alias NameAnti-GITR antibody (Checkpoint Therapeutics)CK-302
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionAnti Glucocorticoid-induced tumor necrosis factor receptor-related protein
TargetsGlucocorticoid-induced tumor necrosis factor receptor-related protein
Therapy Area/IndicationsSolid tumoursHematologic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesDana-Farber Cancer Institute
China Registration ClassN/A

Develop Information

Active CompaniesCheckpoint Therapeutics Inc
Inactive CompaniesDana-Farber Cancer Institute
Active IndicationsSolid tumours
Inactive IndicationsHematologic Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A